[ Price : $8.95]
FDA warns South Koreas Aju Pharm about QS and MDR violations in its production of two Class 2 medical devices.[ Price : $8.95]
FDA says there will be no advisory committee review of Capricor Therapeutics BLA for Deramiocel, the companys lead cell therapy ca...[ Price : $8.95]
CDER acting director Jacqueline Corrigan-Curay decides to retire and will leave her post next month.[ Price : $8.95]
GE HealthCare recalls certain Carestation anesthesia devices due to the risk that they may not provide effective ventilation in ce...[ Price : $8.95]
New data from a Phase 2 study on Eli Lillys experimental bimagrumab showed that when combined with Novo Nordisk's Wegovy (semaglut...[ Price : $8.95]
FDA posts an International Council for Harmonization draft guideline entitled Stability Testing of Drug Substances and Drug Produc...[ Price : $8.95]
A new study disputes previous assumptions about FDA inspections leading to more drug shortages at facilities receiving GMP citatio...[ Price : $8.95]
FDA approves a Daiichi Sankyo BLA for Datroway (datopotamab deruxtecan-dlnk) for certain adults with locally advanced or metastati...